Who do you think is pouring money into the campaigns against the legalization initiaves that will go before the voters in five states next month?

Well, an Oct. 22 exposé in the Guardian has confirmed what we already knew.

In August, the pharmaceutical company Insys Therapeutics became the biggest donor to the campaign to defeat Arizona’s Proposition 205, making a $500,000 donation to Arizonans for Responsible Drug Policy (ARDP). In making the donation, Insys cited concerns for child safety. But the Guardian points out the delicious irony: Insys manufactures Subsys—a prescription painkiller derived from fentanyl—a synthetic opioid that is up to 100 times more powerful than morphine. And the Phoenix New Times adds that Insys is under investigation in four states, including Arizona, for marketing practices related to Subsys that have allegedly resulted in patient deaths.

We’re now just two weeks away from the November 8th election. And this year, nine statewide cannabis initiatives are on the ballot. One of these is Florida’s Amendment 2, which would legalize medical cannabis for those who receive a recommendation from a physician.

In 2014, a similar measure, also put forth by the group United for Care, failed to pass into law despite receiving over 50% of the vote. This year’s initiative also requires 60% of voter support to pass.